In Vitro Toxicity Evaluation of Engineered Cadmium-Coated Silica Nanoparticles on Human Pulmonary Cells

Cytotoxicity of cadmium-containing silica nanoparticles Cd-SiO(2)NPs (0.05-100 mu g/mL) versus SiO(2)NPs and CdCl2 was evaluated by an in vitro test battery in A549 by assessing (i) mitochondrial function, (ii) membrane integrity/cell morphology, (iii) cell growth/proliferation, (iv) apoptotic pathway, (v) oxidative stress, after short-(24-48h) and long-term(10 days) exposure. Both Cd-SiO(2)NPs and CdCl2 produced dose-dependent cytotoxic effects: (i) MTT-assay: similar cytotoxicity pattern was observed at both 24 and 48h, with a more Cd-SiO(2)NPs pronounced effect than CdCl2. Cd-SiO(2)NPs induced mortality (about 50%) at 1 mu g/mL, CdCl2 at 25 mu g/mL; (ii) calcein-AM/PI staining: decrease in cell viability, noticeable at 25 mu g/mL, enhanced markedly at 50 and 100 mu g/mL, after 24 h. Cd-SiO2 NPs induced higher mortality than CdCl2 (25% versus 4%, resp., at 25 mu g/mL) with further exacerbation after 48h; (iii) clonogenic assay: exposure for longer period (10 days) compromised the A549 proliferative capacity at very low dose (0.05 mu g/mL); (iv) a progressive activation of caspase-3 immunolabelling was detected already at 1 mu g/mL; (v) GSH intracellular level was modified by all compounds. In summary, in vitro data demonstrated that both Cd-SiO(2)NPs and CdCl2 affected all investigated endpoints, more markedly after Cd-SiO(2)NPs, while SiO(2)NPs influenced GSH only.